Summary of Key Information:
Acquirer / Seller / Promoter:
Morita Investment Limited (MIL) - a wholly owned subsidiary of Morita Chemicals Industries Co. Limited (MCL)
Target Company:
Neogen Morita New Materials Limited (NML)
Stock Exchange Listings:
NML is an unlisted public limited company
Nature of Transaction / Event:
Preferential issue of equity shares
Date of Transaction:
26/09/2026 (Board and shareholder approval date)
Number of Shares Affected:
7,20,000 Equity Shares
% of Total Shareholding / Voting Capital Affected:
9.09% post-issuance stake for MIL
Mode of Transaction / Action:
Preferential issue basis
Consideration (if disclosed):
₹76.80 crore (Rupees Seventy Six Crore Eighty Lakh only)
Shareholding / Promoter Snapshot (Before & After):
Before Transaction / Event (MIL):
- Shares Held: 0
- % of Total Capital: 0%
After Transaction / Event (MIL):
- Shares Held: 7,20,000
- % of Total Capital: 9.09%
Other Noteworthy Information:
- The preferential issue was approved by the Board of Directors of NML and shareholders at an Extra-Ordinary General Meeting held on September 26, 2026
- The issuance is in accordance with the Joint Venture Agreement entered into by Neogen Ionics Limited (wholly owned subsidiary of Neogen Chemicals Limited) and MIL on August 31, 2025
- Subject to approval of Members of Neogen Chemicals Limited and other necessary statutory and regulatory approvals
- Issue price: ₹1,066.66 per Equity Share (Face value: ₹10, Premium: ₹1,056.66)
- NML is a wholly owned subsidiary of Neogen Ionics Limited and stepdown subsidiary of Neogen Chemicals Limited
- Since NML is unlisted, SEBI ICDR Regulations lock-in requirements are not applicable
Analyst Notes:
The disclosure is made pursuant to Regulation 30(9) read with Schedule III of SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The transaction represents a strategic investment as part of a joint venture arrangement between the Neogen group and Morita group companies.